InMed Pharmaceuticals (INM) EPS (Diluted) (2021 - 2026)
InMed Pharmaceuticals (INM) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 7.27 |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.39 |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.56 Mn | 1.32 Mn | - | -0.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | -1.34 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | -3.64 |
| Sep 30, 2024 | -2.71 |
| Jun 30, 2024 | -5.07 |
| Mar 31, 2024 | -3.58 |
| Dec 31, 2023 | -3.71 |
| Sep 30, 2023 | -15.24 |
| Jun 30, 2023 | -2.75 |
| Mar 31, 2023 | -12.00 |
| Dec 31, 2022 | -18.24 |
| Sep 30, 2022 | -81.10 |
| Jun 30, 2022 | -280.66 |
| Mar 31, 2022 | -122.80 |
| Dec 31, 2021 | -154.64 |
| Sep 30, 2021 | -123.33 |